The Atal Incubation Centre (AIC) at the Centre for Cellular and Molecular Biology (CCMB) in collaboration with Humane Society International/ India (HSI/India) launched the Centre for Predictive Human Model Systems, a center dedicated to enable a paradigm shift in science by focusing on 21st century new approach methodologies instead of animal models.

The center aims to prioritize investment in human-based, non-animal methodologies in life sciences research in India. This will be done by establishing a multi – stakeholder think-tank that represents the growing body of expertise on new approach methodologies on a scientific and policy level, keeping in mind the 21st century biomedical science and toxicology motive globally to break siloes and forge partnerships among the scientific community for better flow of knowledge, support for research and open-access publication of literature will be focused upon.

Dr Madhusudan Rao, CEO of AIC – CCMB said, “This center is a natural alignment to AIC’s objective of supporting new innovation and technologies. This sector of predictive human biology is ripe for investment and I am certain that this partnership with HSI/India will kindle the much-needed investment in this field.”

Alokparna Sengupta, Deputy Director at HSI/India said, “We are excited about the collaboration which has helped establish the center. With the uniqueness that the center brings, we endeavor to plug the loopholes that the health research faces. We aim for this center to be the pioneer in promoting advanced, accurate, reliable science which is also more ethical.”

Researchers have been critically assessing the validity and reliability of data obtained from animal experimentation to predict human outcomes and develop a better understanding of the human physiology. New approach methodologies that do not involve the use of live animals are demonstrating more human relevance and thus promise improved outcomes for human health protection and medical interventions. This collaboration envisions a future for India to be a key player in 21st century biomedical and toxicological research through investment, capacity building, and policy level changes.

Source & Credit: BIOMED21.ORG

Pic Source: Twitter

The center aims to prioritize investment in human-based, non-animal methodologies in life sciences research in India.